Author:
Kritikos Minos,Clouston Sean A. P.
Publisher
Springer International Publishing
Reference111 articles.
1. U.S. Food and Drug Administration. FDA clears new system to perform simultaneous PET, MRI scans. 2011. Available from: https://wayback.archive-it.org/7993/20170114063438/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm258700.htm.
2. Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess. 2007;11(44) iii–iv, xi-267.
3. Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, et al. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Health Technol Assess. 2011;15(35):1–192, iii–iv.
4. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007;48(Suppl 1):78S–88S.
5. Branstetter BF, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology. 2005;235(2):580–6.